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Abstract
A fluorescent peptide substrate was used to measure dephosphorylation by protein tyrosine
phosphatases (PTP) in cell lysates, and single cells and to investigate the effect of environmental
toxins on PTP activity in these systems. Dephosphorylation of the substrate by PTPN1 and PTPN2
obeyed Michaelis-Menten kinetics, with KM values of 770 ± 250 nM and 290 ± 54 nM,
respectively. Dose-response curves and IC50 values were determined for the inhibition of these
two enzymes by the environmental toxins Zn2+ and 1,2-naphthoquinone, as well as pervanadate.
In A431 cell lysates, the reporter was a poor substrate for peptidases (degradation rate of 100 ± 8.2
fmol min−1 mg−1) but an excellent substrate for phosphatases (dephosphorylation rate of 1.4 ± 0.3
nmol min−1 mg−1). Zn2+, 1,2-naphthoquinone and pervanadate inhibited dephosphorylation of the
reporter in cell lysates with IC50 values of 470 nM, 35 μM, and 100 nM, respectively.
Dephosphorylation of the reporter following loading into living single cells occurred at rates of at
least 2 pmol min−1 mg−1. When single cells were exposed to 1,2-naphthoquinone (50 μM), Zn2+
(100 μM), and pervandate (1 mM), dephosphorylation was inhibited with median values and first
and third quartile values of 41 (Q1 = 0%, Q3 = 96%), 50 (Q1 = 46%, Q3 = 74%), and 53% (Q1 =
36%, Q3 = 77%), respectively, demonstrating both the impact of these toxic exposures on cell
signaling and the heterogeneity of response between cells. This approach will provide a valuable
tool for the study of PTP dynamics, particularly in small, heterogeneous populations such as
human biopsy specimens.
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The human genome encodes 107 protein tyrosine phosphatases (PTPs),1 enzymes containing
a catalytic cysteine residue capable of removing phosphoryl moieties from tyrosine residues
on proteins. This enzyme family plays a critical role in maintaining proper cell signaling
through its opposition of protein tyrosine kinases and dysregulation of these key enzymes is
associated with many diseases, including type I diabetes mellitus, cancer, and rheumatoid
arthritis.2 PTP inhibition is also linked to the toxicity associated with inhalation of diesel
exhaust particles (DEP), an important component of air pollution.3 Combustion of diesel
fuel by vehicles and industrial equipment produces fine particulate matter (diameter < 2.5
μm) containing a mixture that includes elemental carbon, polyaromatic hydrocarbons, and
metals.4 The deposition of these particles in small airways and alveoli is associated with
numerous human health hazards including heart attacks, arrhythmias, chronic obstructive
pulmonary disease (COPD), and asthma.5 In vitro studies have linked DEP components to
reactive oxygen species production6 as well as direct inhibition of PTPs.7
Although studies on purified PTPs, cell lysates, and fixed tissue samples have provided
valuable insight into the role of diesel exhaust particles in human disease, analysis of ex
vivo samples acquired from human subjects remains challenging. Bronchial brushing (BB)
is a well-established method of obtaining airway cells for analysis by dislodging them with a
brush in conjunction with fiberoptic bronchoscopy.8 Although BB samples are a valuable
source of primary airway cells for research, the sample size is typically very limited (0.8–3.6
× 104 cells).9 The small sample size is further complicated by the specimen heterogeneity
which in addition to the intact airway epithelia contains mucus, stromal tissue, and the
remnants of cells killed during dislodging. To date, direct analysis of these specimens has
focused on genetic techniques including fluorescence in situ hybridization (FISH),10 RNA
microarrays,11 and polymerase chain reaction (PCR).12 Although these approaches provide
valuable information, new analytical tools for these BB specimens are required to provide
additional information about the biochemistry of human airway cells.
The direct measurement of cell processes by chemical cytometry has the potential to provide
unique advantages in the study of BB specimens. Although a wide range of chemical
cytometry approaches exist,13 the measurement of PTP activity in airway specimens must be
compatible with very small numbers of heterogeneous primary cells, and single-cell CE-LIF
is a promising approach to address this challenge. Sample heterogeneity is readily addressed
by the selection and analysis of individual cells, while the high separation efficiency and
detection limits approaching 10−21 mol14 have made it possible to study many aspects of
single cells, including protein and lipid kinase activity, proteolysis, nitric oxide release, and
response to oxidative stress.14–15 Because PTPs are part of a complicated signaling network,
the ability to multiplex measurement of several enzymes is very attractive, and CE has been
used for monochromatic detection of up to 20 analytes simultaneously16 and multicolor
systems have also been described.17
Herein we demonstrate the utility of single-cell capillary electrophoresis for the
measurement of PTP activity in single intact cells, a technology well-suited for analysis of
small heterogeneous samples such as that from a BB. We developed and validated a
fluorescent peptide reporter of PTP activity and measured the kinetics of dephosphorylation
by two common model phosphatases. Additionally, we observed inhibition of these
phosphatases by three toxins known to be present in diesel exhaust and then generated dose-
response curves for the environmental toxins. A separation method for the peptide and all
possible fluorescent cleavage products was developed so that peptide cleavage in cell lysates
and intact cells could be quantified. The lifetime of the peptide, dephosphorylation rate and
influence of environmental toxins was assessed in A431 cell lysates. Finally, the peptide
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lifetime and the dephosphorylation rate in single A431 cells were quantified in the presence
and absence of environmental toxins.
EXPERIMENTAL SECTION
Peptide Synthesis
The full-length substrate peptide, termed “pTS13” when phosphorylated and “TS13” when
nonphosphorylated, was synthesized using standard solid-phase peptide synthesis techniques
on TGR resin, while peptide acid fragments were synthesized on 2-chlorotritylchloride resin,
both using an automated peptide synthesizer (PS3, Protein Technologies, Tuscon, AZ).
Capillary Electrophoresis
Separation of the peptide reporter based on phosphorylation status was performed using 140
mM borate, 150 mM SDS, 50 mM NaCl in a bare fused-silica capillary [30 μm inner
diameter, 350 μm outer diameter, (Polymicro Technologies, Phoenix, AZ)] . Separations
were performed on either a ProteomeLab PA800 (Beckman Coulter, Fullerton, CA) with a
30 cm long capillary, or on a customized system with a 38 cm long capillary.
Recombinant Phosphatase Activity Assay
Dephosphorylation of peptide by recombinant human PTPN1 and PTPN2 was observed with
and without the PTP inhibitors pervanadate, 1,2-naphthoquinone, and zinc. The PTPN1 used
was a human, N-terminal GST-tagged construct (residues 1-321) while the PTPN2 was a
human construct (residues 1-341), both expressed in E. coli. For some reactions, PTP was
incubated with the environmental toxins pervanadate, 1,2-naphthoquinone, or zinc
pyrithione for 10 min at 21 °C prior to addition of pTS13.
Cell Culture
A431 cells, a human epidermoid carcinoma cell line expressing high levels of EGFR,18 were
grown in a humidified atmosphere at 37 °C and 5% CO2. Cells were cultured in 75 cm2
tissue culture flasks in DMEM (10 (v/v) % FBS, 1 (v/v) % P/S) and were passaged at 60–
80% confluency using 0.25% trypsin.
Cell lysate experiments
A431 cells from two 75 cm2 culture flasks were trypsinized for 5 min, diluted in DMEM,
centrifuged 2 min at 800 × g, and then washed twice with PBS and pelleted. After removal
of the supernatant, the pellet was resuspended in lysis buffer (20 mM HEPES, 1% Triton
X-100, 10% Glycerol, 200mM NaCl, 5 mM β-glycerophosphate) with 1 (v/v) % Sigma
Protease Inhibitor Cocktail. Lysate was mixed end-over-end for 20 min, followed by
centrifugation at 15000× g for 40 min. The supernatant was transferred to a fresh 1.5 mL
tube and protein concentration was measured as previously reported19. Lysates were then
diluted to 10 mg/mL total protein and stored at −20 °C for up to 1 month.
For phosphatase assays, cell lysates were diluted to 111 ng/μL total protein in 90 μL of
reaction buffer (described above) with or without environmental toxins. After 10 min of pre-
incubation, pTS13 in water was added to a final concentration of 280 nM and the reaction
was allowed to proceed for 90 s. Reactions were stopped by addition of an equal volume of
200 μM HCl. Samples were analyzed by CE to establish percent dephosphorylation and to
determine if fluorescent peaks in addition to the intact phosphorylated and
nonphosphorylated peptide appeared on the electropherograms. Dephosphorylation rates
were reported as nmol peptide per minute per mg total cell protein (nmol min−1 mg−1). For
inhibition experiments, dose response curves were generated over a range of inhibitor
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concentrations and IC50 values were interpolated by regression of the linear portion of the
semi-log plot of percent inhibition versus log10 of inhibitor concentration.
Single Cell Phosphatase Measurement
A431 cells were grown in DMEM on cell chambers comprising a round 25 mm diameter
No. 1 glass coverslip bonded to a silicone O-ring (18 mm internal diameter) with PDMS.
Pretreatment of cells, if any, was performed by removing media from a cell chamber, rinsing
twice with 37 °C serum-free DMEM and then adding the appropriate inhibitor dissolved in
serum-free DMEM and incubating at 37 °C for 10–20 min. After pretreatment, a cell
chamber was placed on the microscope stage of the customized single-cell CE system,20 a
cell was visualized and microinjected with a mixture of peptide reporter and internal
standard using a Transjector 5246 microinjection system (Eppendorf AG, Hamburg,
Germany). The cell chamber temperature was maintained at 37 °C using a constant flow of
warmed extracellular buffer (ECB; 10 mM HEPES, 135 mM NaCl, 5 mM KCl, 1 mM
CaCl2, 1 mM MgCl2, pH 7.4) during microinjection, reporter incubation, and cell lysis. At
60 s post-microinjection, the cell was lysed with a 532 nm ND:YAG pulsed laser21 and
electrokinetically injected into the capillary by applying a negative potential to the capillary
outlet reservoir (5 s at 79 V/cm). The capillary inlet was then repositioned into a reservoir of
electrophoretic buffer (140 mM borate, 150 mM SDS, 50 mM NaCl, pH 7.0),
electrophoresis was performed (263 V/cm), and data was analyzed using Matlab and Origin.
Data from untreated and inhibitor treated cells was compared using bootstrapping22 (details
in Supplemental Information) and p-values were reported.
RESULTS AND DISCUSSION
Peptide Selection and Separation
In order to measure PTP activity in single cells, a phosphotyrosine-containing peptide
reporter sequence (Glu-Glu-Leu-Glu-Asp-Asp-pTyr-Glu-Asp-Asp-Nle-Glu-Glu-amide,
where Nle is norleucine) was chosen. The sequence was adapted from a peptide substrate of
epidermal growth factor receptor (EGFR),23 a receptor tyrosine kinase opposed by
phosphatases including PTPN1, PTPN2, SHP-1, and Cdc25A.24–25 6-FAM was conjugated
to the N-terminus to permit fluorescence detection. Since incubation of peptides in cells or
cell lysates can result in their metabolism by peptidases with cleavage at any peptide bond,
the ability to electrophoretically separate pTS13, TS13 and their fluorescent fragments
which are similar in charge/mass was critical for use of pTS13 as a reporter in cell lysates
and single cells. Moreover it was critical that the sample matrix used for the separation be
that of a physiologic buffer since the ultimate goal of this work was measurement of single-
cell, reporter dephosphorylation during toxin exposure.
Initial methods development focused on the separation of pTS13 and TS13. A survey of
separation buffers previously reported for peptides and highly negative analytes comprised
borate with and without sodium dodecyl sulfate (SDS) or cetyltrimethlammonium bromide
(CTAB), sodium citrate, sodium phosphate with SDS, tris(hydroxymethyl)aminomethane
(Tris), and 1,1-bis(hydroxymethyl)ethyl)glycine (Tricine).26 The best resolution observed
during this screening was 1.3 ± 0.1 for 140 mM borate, 70 mM SDS, pH 7.5. This
concentration of SDS is well above its critical micelle concentration (7.9–8.3 mM)27 and
thus the mode of separation was expected to be micellar electrokinetic capillary
chromatography, modified by borate complexation. For both lysate and single-cell analyses,
the sample matrix was not the electrophoretic buffer but a high-salt biocompatible buffer.
When pTS13 and TS13 were loaded into the capillary using a high-salt, neutral-pH buffer
(ECB) as the sample matrix, the peaks were no longer resolved (Figure 1a). The loss in
separation capacity was most likely due to destacking of the analytes in the high ionic
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strength sample matrix. To minimize destacking when using high salt samples, 50 mM
sodium chloride was added to the electrophoretic buffer to more closely match the ionic
strength of the sample matrix i.e. physiologic buffer, and SDS concentration was increased
to 150 mM to increase micellar sweeping effects. Although the added salt minimized
destacking, it resulted in a greatly increased current flow through the capillary necessitating
electrophoretic separations at very low field strengths (≤ 160 V/cm) and consequent long
separation times (1680 ± 54 s for TS13, 1760 ± 63 s for pTS13). For this reason, all
subsequent separations were performed in a 30 μM ID capillary to maintain acceptable field
strengths (260 V/cm) at low currents and shorter separation times (1170 ± 22 s for TS13,
1230 ± 26 s for pTS13). These conditions yielded separation of pTS13 and TS13 with a
resolution of 3.4 ± 0.1, and efficiencies of 7.3 ± 0.6 × 104 (TS13) and 6.7 ± 0.5 × 104
(pTS13) theoretical plates (Figure 1b). Importantly, the ratio of the peak areas of pTS13 and
TS13 to that of the total peptide was highly reproducible with an RSD of 0.032 and 0.023,
respectively. Although these efficiencies are lower than for many peptide separations by CE,
the highly negative analytes and high-salt sample matrix make this a challenging separation.
Most important, the resolution was sufficient for the intended biological application. The
limit of detection for pTS13, defined as the smallest amount of analyte detectable with a
signal-to-noise ratio greater than 3, was determined to be 4.4 × 10−20 mol.
The phospho- and nonphospho-peptides migrated 60 s apart; however, this spacing was not
sufficient to consistently identify single peaks given the variability in the migration time
especially in the presence of potentially biofouling constituents such as protein or cell
debris. For this reason, 6-FAM was used as an internal standard for all biologic samples.
This dye is detectable by LIF and migrates near TS13 and pTS13. The 12 possible
fluorescent fragments generated by removal of C-terminal residues from TS13 were
synthesized. Separation of all analytes simultaneously (Figure 1c) demonstrated that no
fragments co-migrated with 6-FAM, pTS13, or TS13, and thus any degradation of the
reporter within the biologic sample will produce additional CE peaks.
Kinetics of in vitro Dephosphorylation
The human enzymes PTPN1 (PTP-1B) and PTPN2 (TC-PTP) favor substrates with acidic
side-chains proximal to the phosphotyrosine residue, and are implicated in airway
inflammation.28–30 To determine if phosphatase activity could be measured using pTS13,
the reporter at varying concentrations was incubated with recombinant PTPN1 and PTPN2.
Product formation was quantified by CE and the percent dephosphorylated peptide was
calculated as the ratio of the integrated area of the TS13 peak to the combined area of the
pTS13 and TS13 peaks. The Michaelis constant (KM), maximal reaction velocity (Vmax),
and turnover number (kcat) were determined for pTS13 dephosphorylation by PTPN1 and
PTPN2 (Table 1) by fitting the initial rates of product formation to the Michaelis-Menten
equation. PTPN1 and PTPN2 showed first order kinetics with respect to pTS13
dephosphorylation. Previous studies of peptide substrates for PTPN1 have reported KM
values of 2.6–23 μM, with kcat values of 55.7–78.9 s−1,31–32 comparable to the values
observed for pTS13. The kinetics of PTPN2 are less well documented, but a KM for
phosphotyrosine was measured to be 300 μM,33 which is approximately 1000-fold higher
than that seen for pTS13. This is consistent with previous studies comparing PTP
dephosphorylation for peptide substrates and phosphotyrosine alone.32 In summary,
Michaelis-Menten kinetics measured with recombinant phosphatases and pTS13 are
consistent with the existing literature, establishing the utility of this method for studying
PTP activity in vitro.
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Inhibition of Recombinant Enzymes by Toxins From Diesel Exhaust
Inhibitors of PTP activity were chosen to represent three major mechanisms of
environmentally relevant PTP inhibition: active site cysteine oxidation, covalent
modification, and non-oxidative inhibition by transition metals.34 Vanadium is a heavy
metal found in fossil fuels and is released during combustion.35 Several oxidation states of
vanadium are established PTP inhibitors, including pervanadate, which acts through direct
oxidation of the catalytic cysteine.36 The polycyclic aromatic hydrocarbon 1,2-
naphthoquinone is a naphthalene derivative generated by diesel combustion and petroleum
processing which covalently and irreversibly arylates cysteine and histidine residues in the
PTP active site.7 Finally, zinc is a major transition metal component of diesel exhaust
particles that is theorized to inhibit PTP action by a non-redox mechanism involving direct
interaction with vital active site residues.37
To establish whether PTP inhibition could be measured using our phosphatase activity
reporter, pTS13 was incubated with recombinant PTPN1 and PTPN2 in the presence of the
aforementioned inhibitors across a range of concentrations. The enzyme was pretreated with
sodium pervanadate, 1,2-naphthoquinone, or Zn2+, then pTS13 dephosphorylation was
assessed by CE. Dose-response curves were generated (Figure 2) to establish this system as
a useful method for measurement of PTP inhibition in vitro. For PTPN1 inhibition, IC50
values for 1,2-naphthoquinone, pervanadate and Zn2+ were determined as 520 nM, 59 nM,
and 28 μM respectively. IC50 values for these compounds with PTPN2 were found to be 53
nM, 39 nM, and 87 μM. These data are similar to previous reports of PTPN1 inhibition with
1,2-naphthoquinone (IC50: 1.6–5 μM),7, 38 pervanadate (IC50: 400 nM),36 and PTPN2
inhibition with Zn2+ (85% inhibition at 100 μM).39 The difference in inhibition between
PTPN1 and PTPN2 for 1,2-napthoquinone is likely due to the complex mechanism of
inhibition associated with this agent.
Lifetime of pTS13/TS13 in Cell Lysates
To assess reporter susceptibility to intracellular degradation, TS13 was incubated with A431
cell lysates and samples were analyzed by CE. One additional peak appeared over 3 hours.
This breakdown product was identified as the 8 residue fragment (6FAM-EELEDDYE-
COOH) based on co-migration with the synthetic fragment. The average rate of formation,
and thus reporter breakdown, was 100 ± 8.2 fmol min−1 mg−1. This rate is approximately
104 times slower than the dephosphorylation rate measured in A431 lysates (discussed
below), suggesting that TS13 is sufficiently robust to degradation for its intended
applications. Several peptides have been shown to undergo rapid degradation in cell lysates
at rates ranging from 1.4–13 nmol min−1 mg−1,40–41 approximately 104–105 fold faster than
observed for TS13. The peptidase resistance of TS13 is consistent with the finding that both
glutamic and aspartic acid, the two most prevalent residues in this reporter, are moieties not
preferred by peptidases.41
PTP activity and Inhibition in A431 Cell Lysates
Unlike an isolated recombinant enzyme, cellular PTP activity is opposed by tyrosine
kinases. To determine if PTP activity could be measured in the context of cellular contents,
pTS13 was incubated with whole cell lysates generated from A431 epidermoid carcinoma
cells with and without the previously described environmental toxins (Figure 3). In the
absence of inhibitors, pTS13 dephosphorylation occurred at a rate of 1.4 ± 0.3 nmol min−1
mg−1. Toxin inhibition of total PTP activity in A431 lysates was similar to that seen in
recombinant PTPs, with IC50 values of 470 nM, 100 nM, and 35 μM for 1,2-
naphthoquinone, pervanadate, and Zn2+ respectively. These values are comparable to those
seen for recombinant PTPs, and agree with previously reported C6 cell lysate inhibition by
Zn2+ (IC50: 31 μM).37
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Lifetime of pTS13/TS13 in Single Cells
The degradation resistance of the PTP reporter in living cells was tested by microinjection of
single A431 cells with TS13 and single-cell analysis by CE. A single degradation product
was observed and corresponded to the 8 residue fragment based on migration relative to
TS13. This suggests that degradation patterns for TS13 in intact A431 cells and lysates are
similar. The degradation rate was linearly correlated (R2 = 0.8) with amount of TS13
injected, suggesting first-order kinetics. The amount of peptide delivered ranged from 0.2–
35 amol and the median degradation rate was 39 fmol min−1 mg−1 with first and third
quartiles (Q1 and Q3) of 22 and 440 fmol min−1 mg−1, similar to the rate observed in A431
cell lysates. The median half-life for TS13 was 35 min (Q1 = 23 min, Q3 = 39 min),
approximately 250-fold longer than a previous report for a native peptide in living cells.42
Single A431 Cell PTP Activity
Cell lysates lack the organization and compartmentalization of the intact cell and represent
the pooled average of all processes occurring within a population, obscuring any
intercellular heterogeneity. To demonstrate the utility of pTS13 as a reporter of enzyme
activity in single cells, individual A431 cells were analyzed with and without pretreatment
with environmental toxins (Figure 4). In untreated cells, a median of 0% (Q1 = 0%, Q3 =
11%) remaining phosphorylation was observed after 60 s. For the majority of these cells,
100% dephosphorylation had occurred within this time frame, so rates could not be
calculated. A lower limit to the rate was estimated by assuming a total protein concentration
of 1 g/mL and a 500 fL cell volume43 for the average mammalian cell. The median rate was
2.1 pmol min−1 mg−1 (Q1 and Q3 of 1.1 and 8.0 pmol min−1 mg−1), significantly lower than
seen in lysates, however this difference is overestimated by the inability to calculate exact
rates for single cells, i.e. if 100% dephosphorylation is achieved in less than 60 s, actual
rates will be higher than those calculated. Compartmentalization of PTPs within the intact
architecture of living cells could also contribute to lower dephosphorylation rates in single
cells. Plots of percent dephosphorylation vs. amount of peptide delivered showed that across
the mass range observed (0.5–33 amol), PTP activity was not saturated. Treatment of A431
cells with sodium pervanadate (1 mM) prior to microinjection resulted in a median of 53%
(Q1 = 36%, Q3 = 77%) phosphorylation remaining in 60 s. Results of 1,2-naphthoquinone
(50 μM) and zinc pyrithione (100 μM) pretreatment were similar, yielding 41% (Q1 = 0%,
Q3 = 96%) and 50% (Q1 = 46%, Q3 = 74%) median phosphorylation remaining after 60 s,
respectively. Comparison of dephosphorylation for each treatment group versus untreated
controls found statistically significant inhibition with p-values of 0.035, 0.0072, and 0.002
for 1,2-napthoquinone, zinc pyrithione, and pervanadate. The measurement of the relative
peak area of pTS13 to that of total peptide peak area in the presence of a lysed single cell
was highly reproducible (RSD = 0.018). Prior work has shown that the termination of
intracellular reactions by laser lysis44 and the introduction of cell contents into the capillary
by electrokinetic injection21 are highly reproducible. Thus the most likely source of the
measured variability in the PTP activity is the cellular heterogeneity in signaling.
The concentrations of 1,2-naphthoquinone and pervanadate necessary to ellicit 50%
inhibition of PTP activity in single cells are 3 orders of magnitude higher than for lysates,
while there is little difference seen for zinc pyrithione. Although the ionophore pyrithione
aids entry of Zn2+ into cells, pervanadate has no such ionophore or any established
membrane transporter, potentially limiting its access to the cytoplasm. 1,2-naphthoquinone
is highly lipophilic and may partition extensively in the cell membrane. Additionally, unlike
for Zn2+, inhibition of PTPs by pervanadate requires oxidation, and the antioxidative
machinery of intact cells has not been diluted or disorganized as is the case in a lysate.
Exposure of intact cells to these toxins clearly inhibits PTP activity, and the variability
between cells observed in these studies is consistent with previous reports of phenotypic
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heterogeneity in clonal populations,45 underlining the value of single-cell measurements as
compared to bulk analysis of many cells.
CONCLUSION
A novel chemical cytometry approach to measure PTP activity was demonstrated for
analysis of recombinant enzymes in vitro, cell lysates, and single cells. In each system, total
PTP activity was assessed by measuring dephosphorylation of a fluorescent substrate
peptide. Inhibition of PTP activity by environmental toxins was observed for recombinant
enzymes and lysates at levels similar to those previously reported. In single A431 cells,
pretreatment with all toxins reduced PTP activity relative to untreated cells, with substantial
variation between cells. This heterogeneity seen in cultured cells illustrates the value of
analyzing individual cells rather than population averages.
This approach provides several advantages over existing techniques. The simplicity of
sample preparation and assay protocols makes this technique an attractive option for
analysis of recombinant enzymes and cell lysates, and the high sensitivity and flexibility is
well suited to analysis of intact single cells. This system does not require genetic
manipulation of cells, making it useful for analysis of primary cells. The ability to pre-select
individual cells using microscopy permits analysis of desired subpopulations of viable cells
in low viability or highly complex samples as well as very small samples. These
characteristics in particular suggest this technique will be valuable in the analysis of
specimens such as airway brush biopsies and tumor samples. Additionally, enzyme activity
is measured directly without the need for antibodies which, combined with the analytical
separation and tunability of a peptide substrate reporter, allows for simultaneous multiplexed
measurements of several signaling events. The ability to analyze the effects of extracellular
insults on signaling in small, heterogeneous samples of primary cells promises to be a
valuable new research tool in environmental health research in particular as well as the
larger field of cell signaling.
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Separation of pTS13 (P) and TS13 (N) in 140 mM borate, 70 mM SDS, pH 7.4 in a 50–μm
diameter capillary (A) or with 140 mM borate, 150 mM SDS, 50 mM NaCl, pH 7.4 in a 30-
μm diameter capillary (B). Reporter species were also separated from all fluorescent
fragments (C), indicated by length in residues (e.g. fragment 1 is 6-FAM-Glu-COOH), as
well as from the 6-FAM internal standard (F).
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(A–C) Recombinant PTPN1 and (D–F) PTPN2 were pretreated with a range of inhibitor
concentrations for 10 min and then incubated with pTS13 for 10 min. Percent inhibition was
calculated relative to the dephosphorylation observed in the absence of inhibitor.
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(A–C) A431 cell lysates (10 μg total protein) were pretreated with a range of inhibitor
concentrations for 10 min and then incubated with pTS13 for 90 s. Percent inhibition was
calculated relative to the dephosphorylation observed in the absence of inhibitor.
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Single A431 cells were incubated in serum-free medium with and without inhibitors,
microinjected with pTS13, and analyzed by CE. Representative electropherograms of (A)
full dephosphorylation in an untreated cell and (B) partial dephosphorylation in a
pervanadate treated cell. (C) Summary of PTP inhibition seen after treatment with (●) no
inhibitor, (○) 1 mM sodium pervanadate, (▼)100 μM zinc pyrithione, or (▽) 50 μM 1,2-
naphthoquinone. The bars represent the median for each measurement.
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Table 1
Kinetic constants KM and Vmax for pTS13 dephosphorylation by recombinant PTPN1 and PTPN2 were
determined by fitting the Michaelis-Menten equation to initial reaction rates obtained over a range of substrate
concentrations. Kcat was calculated as Vmax/[E] where [E] is enzyme concentration.
Enzyme KM (nM) Vmax (nM s−1 ng−1) kcat (s−1)
PTPN1 770 ± 250 2.2 ± 0.25 21 ± 2.4
PTPN2 290 ± 54 3.1 ± 0.18 30 ± 1.7
Anal Chem. Author manuscript; available in PMC 2014 June 18.
